Orexin-A in Patients With Lewy Body Disease: A Systematic Review and Meta-Analysis
BackgroundAbnormal orexin-A levels in cerebrospinal fluid (CSF) have been identified in Alzheimer’s disease (AD) and other neurodegenerative diseases. However, few studies have focused on Lewy body disease (LBD) and often with debatable outcomes. Thus, we performed this systematic review and meta-an...
Guardado en:
Autores principales: | Jinghuan Gan, Zhichao Chen, Jiuyan Han, Lingyun Ma, Shuai Liu, Xiao-Dan Wang, Yong Ji |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/814850451241488e87de83b476a1c9ae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Narcolepsy Type 1: A Remitting Disease? An Unusual Case Report
por: Vellieux G, et al.
Publicado: (2021) -
The hypocretin/orexin system in sleep disorders: preclinical insights and clinical progress
por: Chow M, et al.
Publicado: (2016) -
Tumor cell apoptosis mediated by the orexins
por: A. S. Diatlova, et al.
Publicado: (2021) -
Clinical Characteristics, Iron Metabolism and Neuroinflammation: New Insight into Excessive Daytime Sleepiness in Parkinson’s Disease
por: Hu Y, et al.
Publicado: (2021) -
Occupational Outcomes Associated with Sleep Quality and Excessive Daytime Sleepiness: Results from a National Survey
por: AlShareef SM
Publicado: (2020)